SCHEMBL1426326

SCHEMBL1426326

Brc1ccsn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6442678 0.63
SCHEMBL2024929 0.63
SCHEMBL17675345 0.62
SCHEMBL610831 0.53
SCHEMBL423198 0.53
SCHEMBL246997 0.50 MAPT (0.44)
Methane SCHEMBL21489530 0.42 CYP2A6 (0.89)
SCHEMBL21518322 0.42
SCHEMBL9496102 0.42 CYP2A6 (0.89)
SCHEMBL15521433 0.40 CYP2A6 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637454-B2 Heterocyclic monoacylglycerol lipase (MAGL) inhibitors HOFFMANN-LA ROCHE INC. (US) 2026-05-26 US disclosed
EP-4735430-A1 MALT1 INHIBITORS Janssen Pharmaceutica NV (BE) 2026-05-06 EP disclosed
US-20250388536-A1 3-ALKYNYL CARBOXAMIDES AS AEP MODULATORS HOFFMANN-LA ROCHE INC. (US) 2025-12-25 US disclosed
EP-4652158-A1 NOVEL PYRIMIDINYL SULFONAMIDE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2025-11-26 EP disclosed
US-20250346580-A1 NOVEL PYRIMIDINYL SULFONAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2025-11-13 US disclosed
EP-4638436-A1 PRMT5 INHIBITORS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2025-10-29 EP disclosed
US-12454530-B2 Amido cyclohexane acid derivatives as LPA receptor inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2025-10-28 US disclosed
EP-4634158-A2 INHIBITORS OF PROCASPASE-6 ACTIVATION AND USES THEREOF The Regents of University of California (US) 2025-10-22 EP disclosed
US-12441718-B2 Selective angiotensin II compounds VICORE PHARMA AB (SE) 2025-10-14 US disclosed
US-20250215012-A1 IKZF2 DEGRADERS AND USES THEREOF UNIV MICHIGAN (US) 2025-07-03 US disclosed
US-20110071129-A1 SPIRODIAMINE-DIARYL KETOXIME DERIVATIVE MSD K.K. (JP) 2011-03-24 US disclosed
CN-101553233-A Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases DECIPHERA PHARMACEUTICALS LLC (US) 2009-10-07 CN disclosed
CN-1143962-A Triazole compound and processes for preparation thereof YUHAN CORP (KR) 1997-02-26 CN disclosed
WO-1994021617-A1 A PROCESS FOR PREPARING HALOGENATED ISOTHIAZOLES DOWELANCO (US) 1994-09-29 WO disclosed
CN-1019942-C Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and process for producing them ISHIHARA SANGYO KAISHA (JP) 1993-03-03 CN disclosed
EP-0234352-B1 SULFONAMIDE COMPOUNDS AND SALTS THEREOF, HERBICIDAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR PRODUCING THEM ISHIHARA SANGYO KAISHA, LTD. (JP) 1992-04-29 EP disclosed
US-4835282-A Isothiazoles as intermediates for herbicidal sulfonamides ISHIHARA SANGYO KAISHA LTD. (JP) 1989-05-30 US disclosed
US-4790869-A Sulfonamide compounds and salts thereof, herbicidal compositions containing them ISHIHARA SANGYO KAISHA LTD. (JP) 1988-12-13 US disclosed
CN-86100619-A Power switching device 1987-09-09 CN disclosed
EP-0234352-A1 Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and process for producing them ISHIHARA SANGYO KAISHA, LTD. (JP) 1987-09-02 EP disclosed